Taiga Biotechnologies IPO

www.taigabiotech.com

Taiga Biotechnologies is a cell-based immunotherapy company focused on harnessing the power of the immune system to fight solid tumors and infectious disease.

Founded2006
Total Funding to Date$42.83MM
Register for Details

For more details on financing and valuation for Taiga Biotechnologies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Taiga Biotechnologies Ticker Symbol

Taiga Biotechnologies does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Taiga Biotechnologies Stock Price

The stock price for Taiga Biotechnologies will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Taiga Biotechnologies Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
5/31/2019 Series C $27.2MM raised $XXX.XX $XXX.XX
3/16/2017 Series B-1 $12MM raised $XXX.XX $XXX.XX
5/15/2014 Series B $3.17MM raised $XXX.XX $XXX.XX
5/30/2012 Series A $466.22K raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Taiga Biotechnologies in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector